Skip to content

Effects of tDCS and TUS on the Perception of Pain and Functional Limitations Due to Non-Specific Chronic Low Back Pain

Effects of Transcranial Direct Current Stimulation (tDCS) and Transcranial Ultrasound (TUS) on the Perception of Pain and Functional Limitations Due to Non-Specific Chronic Low Back Pain (NSCLBP).

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02954432
Enrollment
40
Registered
2016-11-03
Start date
2016-11-30
Completion date
2026-09-30
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain, Chronic Pain

Keywords

transcranial Direct Current Stimulation, Transcranial Ultrasound, non-invasive brain stimulation

Brief summary

The purpose of this study is to assess the effects of tDCS in combination with TUS for the treatment of pain and functional limitations in subjects with NSCLBP. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation.

Interventions

DEVICEtranscranial Direct Current Stimulation (tDCS)

Subjects will receive 20 minutes of either active or sham tDCS at an intensity of 2 milliamps (mA). The anodal electrode will be placed over the primary motor cortex contralateral to the most painful side, and the cathodal electrode will be placed over the contralateral supraorbital area. In the sham group, the tDCS device will not be active for the full 20 minutes.

Subjects will receive 20 minutes of either active or sham TUS. During active stimulation the ultrasound will be active for the full 20 minutes- however, during sham stimulation the ultrasound will not be active for the full 20 minutes.

Sponsors

Highland Instruments, Inc.
CollaboratorINDUSTRY
Spaulding Rehabilitation Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

Phase II

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Able to provide informed consent to participate in the study 2. Subjects between 18 to 85 years old 3. Subjects having non-specific chronic low back pain with existing pain for at least 3 months and having pain on at least half the days in the past 6 months with an average of at least 3 on a 0-10 visual analog scale (VAS) scale 4. Pain resistant (partial or no response) to common analgesics and medications for chronic pain used as initial pain management such as Tylenol, Aspirin, Ibuprofen, Soma, Parafon Forte DCS, Zanaflex, and Codeine. 5. Must have the ability to feel sensation by Von-Frey fiber on the forearm

Exclusion criteria

1. Subject is pregnant 2. Contraindications to tDCS in conjunction with TUS, i.e. metallic implant in the brain or implanted brain medical devices 3. History of alcohol or drug abuse within the past 6 months as self reported 4. Use of carbamazepine within the past 6 months as self reported 5. Suffering from severe depression (with a score of \>30 in the Beck Depression Inventory) 6. History of neurological disorders as self reported 7. History of unexplained fainting spells as self reported 8. History of severe head injury resulting in more than a momentary loss of consciousness as self reported 9. History of neurosurgery as self reported 10. Unstable pain 11. Large placebo responder 12. Low adherence during the run-in period 13. Low baseline pain

Design outcomes

Primary

MeasureTime frameDescription
Changes in Mechanical Temporal Summation (Hand)Baseline and 3.5 monthsChanges in Mechanical Temporal Summation (TS) from hand will be measured in order to determine whether anodal transcranial direct current stimulation (tDCS) in conjunction with transcranial ultrasound (TUS) is effective in reducing pain of subjects with non-specific chronic low back pain.
Changes in Conditional Pain Modulation (Hand)Baseline and 3.5 monthsChanges in Conditional Pain Modulation (CPM) will be measured in the hand in order to determine whether anodal transcranial direct current stimulation (tDCS) in conjunction with transcranial ultrasound (TUS) is effective in increasing the pain pressure threshold in subjects with non-specific chronic low back pain.
Changes in PainBaseline and 3.5 monthsChanges in the Visual Analogue Scale (VAS) for pain will be measured in order to measure any changes in pain levels when subjects come in for sessions.

Countries

United States

Participant flow

Pre-assignment details

40 subjects were enrolled and randomized

Participants by arm

ArmCount
Active tDCS + Active TUS - Phase II
Subjects in the experimental group will undergo 20 minutes of active transcranial direct current stimulation (tDCS) and active transcranial ultrasound (TUS). transcranial Direct Current Stimulation (tDCS): Subjects will receive 20 minutes of either active or sham tDCS at intensity of 2 milliamps (mA). The anodal electrode will be placed over the primary motor cortex contralateral to the most painful side, and the cathodal electrode will be placed over the contralateral supraorbital area. In the sham group, the tDCS device will not be active for the full 20 minutes. Transcranial Ultrasound (TUS): Subjects will receive 20 minutes of either active or sham TUS. During active stimulation the ultrasound will be active for the full 20 minutes- however, during sham stimulation the ultrasound will not be active for the full 20 minutes.
20
Sham tDCS + Sham TUS - Phase II
Subjects in the sham group will undergo 20 minutes of sham transcranial direct current stimulation (tDCS) and sham transcranial ultrasound (TUS). transcranial Direct Current Stimulation (tDCS): Subjects will receive 20 minutes of either active or sham tDCS at intensity of 2 milliamps (mA). The anodal electrode will be placed over the primary motor cortex contralateral to the most painful side, and the cathodal electrode will be placed over the contralateral supraorbital area. In the sham group, the tDCS device will not be active for the full 20 minutes. Transcranial Ultrasound (TUS): Subjects will receive 20 minutes of either active or sham TUS. During active stimulation the ultrasound will be active for the full 20 minutes- however, during sham stimulation the ultrasound will not be active for the full 20 minutes.
20
Total40

Baseline characteristics

CharacteristicActive tDCS + Active TUS - Phase IITotalSham tDCS + Sham TUS - Phase II
Age, Continuous49.0 years
STANDARD_DEVIATION 18.6
48.2 years
STANDARD_DEVIATION 17.1
47.3 years
STANDARD_DEVIATION 15.7
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants6 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
14 Participants31 Participants17 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants3 Participants2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Black or African American
2 Participants7 Participants5 Participants
Race (NIH/OMB)
More than one race
2 Participants2 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants3 Participants1 Participants
Race (NIH/OMB)
White
13 Participants26 Participants13 Participants
Region of Enrollment
United States
20 participants40 participants20 participants
Sex: Female, Male
Female
6 Participants20 Participants14 Participants
Sex: Female, Male
Male
14 Participants19 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 20
other
Total, other adverse events
15 / 2013 / 20
serious
Total, serious adverse events
0 / 200 / 20

Outcome results

Primary

Changes in Conditional Pain Modulation (Hand)

Changes in Conditional Pain Modulation (CPM) will be measured in the hand in order to determine whether anodal transcranial direct current stimulation (tDCS) in conjunction with transcranial ultrasound (TUS) is effective in increasing the pain pressure threshold in subjects with non-specific chronic low back pain.

Time frame: Baseline and 3.5 months

ArmMeasureValue (MEAN)Dispersion
Active tDCS + Active TUSChanges in Conditional Pain Modulation (Hand)94 CPM percentage changesStandard Error 22
Sham tDCS + Sham TUSChanges in Conditional Pain Modulation (Hand)-4 CPM percentage changesStandard Error 19
Primary

Changes in Mechanical Temporal Summation (Hand)

Changes in Mechanical Temporal Summation (TS) from hand will be measured in order to determine whether anodal transcranial direct current stimulation (tDCS) in conjunction with transcranial ultrasound (TUS) is effective in reducing pain of subjects with non-specific chronic low back pain.

Time frame: Baseline and 3.5 months

ArmMeasureValue (MEAN)Dispersion
Active tDCS + Active TUSChanges in Mechanical Temporal Summation (Hand)15 TSPS percentage changeStandard Error 8
Sham tDCS + Sham TUSChanges in Mechanical Temporal Summation (Hand)-4 TSPS percentage changeStandard Error 9
Primary

Changes in Pain

Changes in the Visual Analogue Scale (VAS) for pain will be measured in order to measure any changes in pain levels when subjects come in for sessions.

Time frame: Baseline and 3.5 months

ArmMeasureValue (MEAN)Dispersion
Active tDCS + Active TUSChanges in Pain45 percentage changesStandard Error 2.4
Sham tDCS + Sham TUSChanges in Pain24 percentage changesStandard Error 2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026